{"id":"W2165556241","doi":"10.1016/s0140-6736(15)60936-9","title":"Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study","year":2015,"lang":"en","type":"article","venue":"The Lancet","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba","funders":"Eli Lilly and Company; American Diabetes Association","keywords":"Dulaglutide; Medicine; Insulin glargine; Type 2 diabetes; Internal medicine; Metformin; Bedtime; Lixisenatide; Exenatide; Glycemic; Insulin; Regimen; Diabetes mellitus; Randomized controlled trial; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002171797,0.002196398,0.004733048,0.0006958894,0.0004516392,0.001653782,0.001552622,0.002253245,0.008164612],"category_scores_gemma":[0.001974217,0.001123125,0.003126437,0.0006200328,0.001699212,0.002320471,0.0006207523,0.004507055,0.001407402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009954979,"about_ca_system_score_gemma":0.0009323442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001291774,"about_ca_topic_score_gemma":0.002286782,"domain_scores_codex":[0.9991954,0.0004048402,0.00005097757,0.0001408394,0.00006033477,0.000147558],"domain_scores_gemma":[0.9988245,0.0003922459,0.0002006704,0.0001266617,0.00004666975,0.0004092248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9842387,0.004533315,0.0002236399,0.0003249526,0.0006167301,0.00001907187,0.00003290705,0.0001464423,0.001139979,0.00004876578,0.000264044,0.0084114],"study_design_scores_gemma":[0.9541419,0.04401932,0.0008370531,0.00001857381,0.0003110871,0.00001686563,0.00002569184,0.0002104005,0.0001495513,0.00009616856,0.0001576936,0.00001580751],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907525,0.004035122,0.0005510611,0.0006526381,0.0006190785,0.000976507,0.0006919604,0.000168523,0.001552482],"genre_scores_gemma":[0.9882978,0.002597634,0.001661382,0.001037828,0.000539148,0.00133192,0.0006672727,0.00005272358,0.003814506],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008164612,"threshold_uncertainty_score":0.02731335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03752558679091073,"score_gpt":0.3086463844184889,"score_spread":0.2711207976275782,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}